Buyer's guide

The best AEO platform for pharma in 2026 — what to look for

Generative AI is now the first place patients, caregivers, clinicians, and payors go for information about pharmaceutical brands. Pharma Answer Engine Optimization (AEO) is the new category of platform that monitors what AI says — and what to do about it. Here's what to look for, how the existing martech stack handles AI today, and where the new AEO layer fits.

What pharma AEO actually does

A pharma AEO platform asks the major generative AI tools the questions your audiences actually ask — across patient, HCP, caregiver, and payor framings — captures every answer, scores it for visibility, sentiment, accuracy against your approved claims, and competitive share of voice, then surfaces a prioritized action list for the teams who can do something about it.

The five AI tools that matter today: ChatGPT (OpenAI), Claude (Anthropic), Gemini (Google), Perplexity, and Grok (xAI). A serious pharma AEO platform monitors all of them, not just the loudest one.

How the existing pharma martech stack handles AI (it doesn't)

The honest answer: it doesn't. Each major martech category in pharma covers a different layer. None of them monitors generative AI output.

HCP engagement— Veeva CRM, Salesforce Health Cloud, Aktana, Pitcher. Runs the field force. Doesn't touch AI.
MLR / promotional review— Veeva PromoMats, ZINC PromoMats, Aprimo. Reviews your content before it publishes. Doesn't monitor what AI says about it after.
Real-world data & market intelligence— IQVIA, Komodo Health, Clarivate, Definitive Healthcare. Tracks prescriptions, patient journeys, claims data. Doesn't touch generative AI output.
Marketing automation & content— Adobe Experience Manager, Marketo, Sitecore, Veeva CRM Engage. Owned-channel delivery. Doesn't monitor third-party AI tools.
AI Answer Engine Optimization — the new layer. percivo.ai operates here.

Every pharma team buying an AEO platform is buying a new category alongside the existing stack, not replacing anything. That's an important framing for procurement.

What to look for in a pharma AEO platform

Six requirements separate a serious pharma AEO platform from a generic AI monitoring tool that happens to work for any brand:

Coverage of the AI tools that matter. ChatGPT, Claude, Gemini, Perplexity, Grok. Not just one or two. Each engine has a different personality and a different way of citing sources.
A structured methodology.Every monitored prompt should be tagged across audience, lifecycle stage, intent, and brand scope — otherwise the data is descriptive (“we got mentioned 47% of the time”) instead of diagnostic (“AI mentions us 80% on safety prompts but only 35% on cost prompts in the payor audience”).
Per-audience tracking. HCP, patient, caregiver, payor — each has different framing, different prompts, different success criteria.
Approved Claims Library. Accuracy should be measured against your label-aligned claims, versioned per market with effective and expiry dates — not against a generic accuracy heuristic.
Label-boundary / off-label detection.When AI describes your brand for an unapproved indication or patient population, that's a Medical Affairs flag with verbatim evidence — not a commercial-team workload.
MLR-ready outputs. Recommendations must be structured to drop into Veeva PromoMats or ZINC PromoMats review workflows. If your AEO tool generates a wall of FAQ prose that MLR has to rewrite anyway, the value is gone.

Where percivo.ai fits

percivo.ai is the pharma-native AEO platform. It monitors all five major AI tools daily, structures every prompt through the percivo Prism™ methodology (audience × lifecycle stage × intent × brand scope), measures accuracy against an approved-claims library, flags label boundaries for Medical Affairs review, and produces channel-categorized recommendations ready for MLR. Customer data is hosted in the European Union with an append-only audit log and OAuth2/OIDC authentication. SOC 2 is on the roadmap.

percivo.ai is currently in private beta. Access is invitation-only. To request a 7-day demo workspace pre-seeded with real AI visibility data on your brand, see /request-access.

Frequently asked questions

What is a pharma AEO platform?

A pharma Answer Engine Optimization (AEO) platform monitors what generative AI tools (ChatGPT, Claude, Gemini, Perplexity, Grok) say about pharmaceutical brands and surfaces what brand, medical, and market access teams should do about it. Where SEO ranked pages on Google, AEO shapes the single synthesized answer the AI gives a patient, clinician, or payor.

Does Veeva PromoMats do AI monitoring?

No. Veeva PromoMats is a Medical-Legal-Regulatory (MLR) review system for promotional content. It reviews your owned content before it ships. It does not monitor what third-party AI tools say about your brand after the content is published. AEO and PromoMats are complementary, not overlapping — AEO outputs are designed to drop into PromoMats review workflows.

Does Veeva CRM or Salesforce Health Cloud do AI monitoring?

No. Veeva CRM and Salesforce Health Cloud are field-force and engagement platforms. They manage HCP interactions and rep-driven activity. They do not monitor generative AI tools or measure what AI says about a brand to patients, clinicians, or payors.

Does IQVIA, Komodo Health, or Clarivate cover AEO?

No. IQVIA, Komodo Health, Clarivate, and Definitive Healthcare are real-world data and market intelligence providers. They cover prescription data, patient journeys, market sizing, and competitive landscape. They do not monitor what generative AI tools tell users about brands, which is a different data layer entirely.

What should a pharma brand team look for in an AEO platform?

Six things: (1) coverage of the major AI tools the audience actually uses — ChatGPT, Claude, Gemini, Perplexity, Grok; (2) a structured methodology so prompts are comparable across markets, audiences, and time; (3) per-audience tracking (HCP, patient, caregiver, payor) with different framing for each; (4) an approved-claims library so accuracy is measured against the label, not against a generic heuristic; (5) label-boundary / off-label detection routed to Medical Affairs, not commercial; (6) MLR-ready outputs that drop into existing pharma review workflows.

Why isn't a generic AI monitoring tool enough for pharma?

Generic AI monitoring tools (the kind that work for any consumer or B2B brand) treat every mention the same. Pharma has different rules: claims must align with the approved label, content must clear MLR, off-label discussion has regulatory consequences, and HCP framing differs fundamentally from patient framing. A generic tool reports "we got mentioned 47% of the time." A pharma-native tool tells you which prompts, which audiences, which claims AI got wrong, and whether anything looks off-label.

What is the percivo Prism™ and why does it matter?

The percivo Prism™ is a four-dimensional methodology for structuring AI monitoring prompts: audience (patient, caregiver, HCP, payor) × lifecycle stage (Awareness, Trial, Usage) × intent (efficacy, safety, cost, access, treatment options) × brand scope (brand-specific or category-level). Every prompt is tagged across these four axes, so visibility, sentiment, and accuracy numbers are comparable across markets and over time — instead of being an unstructured stream of one-off observations.

How is percivo.ai different from category-newcomer AEO tools?

Category-newcomer AEO tools are general-purpose: they work for tech, consumer goods, SaaS, and pharma in the same way. percivo.ai is purpose-built for pharma — the data model, the analyzer, the recommendations engine, and the methodology are all designed around pharma's regulatory and operational reality (claims library, MLR-ready outputs, off-label routing, indication-level workspaces, audit-grade traceability).

What does pharma AEO replace in the existing martech stack?

Nothing. AEO is a new layer alongside the existing pharma martech stack, not a replacement. Customer engagement still runs on Veeva CRM or Salesforce. MLR review still runs on PromoMats. Real-world data still comes from IQVIA. AEO sits next to all of them and answers a question none of them cover: what is AI saying about your brand right now, and where does that diverge from your label and your evidence?

How long does it take to roll out an AEO platform in pharma?

With percivo.ai, the first brand is white-glove onboarded in roughly one week — brand details, approved claims, owned domains, and a structured PRISM prompt grid are configured, then real AI visibility data starts flowing immediately. Scaling beyond the first brand is a function of how many indications and markets a team wants to track.